In addition, both Cox regression and Kaplan–Meier survival analysis with log-rank test confirmed that tumor with a signature of RUNX3/H3K27me3 co-expression exhibited a better prognosis in the survival analysis, especially in pathologic TNM-I population, which might help outline the high-risk population demanding close surveillance. This evidence concerns the gene RUNX3 and neoplasm.